[3-(Aminomethyl)azetidin-1-yl]-[1-(4-methoxynaphthalen-1-yl)sulfonyl-2,3-dihydroindol-3-yl]methanone | 583814-90-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: [3-(Aminomethyl)azetidin-1-yl]-[1-(4-methoxynaphthalen-1-yl)sulfonyl-2,3-dihydroindol-3-yl]methanone
• CAS: 583814-90-8
• 化学式: C₂₄H₂₅N₃O₄S
• 分子量: 451.546
• InChiKey: DVVPUVMWZHQFNZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  32
• 可旋转键数：
  5
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  101
• 氢给体数：
  1
• 氢受体数：
  6

反应信息

• 作为产物：
  描述：

  1-(4-methoxynaphthalene-1-sulfonyl)-2,3-dihydro-1H-indole-3-carboxylic Acid 、 3-氮杂丁烷甲胺 在 N,N-二异丙基乙胺 、 Methanaminium,N-[(dimethylamino)(3H-1,2,3-triazolo[4,5-b]pyridin-3-yloxy)methylene]-N-methyl-, hexafluorophosphate(1-) 作用下， 生成 [3-(Aminomethyl)azetidin-1-yl]-[1-(4-methoxynaphthalen-1-yl)sulfonyl-2,3-dihydroindol-3-yl]methanone
  参考文献：
  名称：

  The discovery and SAR of indoline-3-carboxamides—A new series of 5-HT6 antagonists

  摘要：

  Antagonists of the 5-HT6 receptor have been shown to improve cognitive function in a wide range of animal models and as such may prove to be attractive agents for the symptomatic treatment of cognitive disorders such as Alzheimer's disease ( AD) and schizophrenia. We report herein the identification and SAR around N-(2-aminoalkyl)-1-(arylsulfonyl)indoline-3-carboxamides-a novel chemotype of 5-HT6 antagonists. (C) 2010 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2010.04.085

文献信息

• The discovery and SAR of indoline-3-carboxamides—A new series of 5-HT6 antagonists
  作者：Mark Reid、Ian Carlyle、Wilson L. Caulfield、Tom R. Clarkson、Fiona Cusick、Ola Epemolu、Robert Gilfillan、Richard Goodwin、David Jaap、Elise C. O’Donnell、Jeremy Presland、Zoran Rankovic、Daniel Spinks、Gayle Spinks、Anne M. Thomson、Fiona Thomson、James Strain、Grant Wishart

  DOI：10.1016/j.bmcl.2010.04.085

  日期：2010.6

  Antagonists of the 5-HT6 receptor have been shown to improve cognitive function in a wide range of animal models and as such may prove to be attractive agents for the symptomatic treatment of cognitive disorders such as Alzheimer's disease ( AD) and schizophrenia. We report herein the identification and SAR around N-(2-aminoalkyl)-1-(arylsulfonyl)indoline-3-carboxamides-a novel chemotype of 5-HT6 antagonists. (C) 2010 Elsevier Ltd. All rights reserved.